Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 60, Issue 4, 2001, Pages 372-379

  Svenungsson, E ^a   Andersson, M ^a   Brundin, L ^a   Van Vollenhoven, R ^a   Khademi, M ^a   Tarkowski, A ^b   Greitz, D ^a   Dahlstrom M ^a   Lundberg, I ^a   Klareskog, L ^a   Olsson, T ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CAPILLARY ELECTROPHORESIS; CEREBROSPINAL FLUID; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN SITU HYBRIDIZATION; INFLAMMATION; LUPUS ERYTHEMATOSUS; LYMPHOCYTE; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWEDEN;

ADULT; AGED; CASE-CONTROL STUDIES; CYTOKINES; ELECTROPHORESIS, CAPILLARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; LYMPHOCYTES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NITRIC OXIDE; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035076074     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.4.372     Document Type: Article

References (39)

1. Lupus erythematosus in the 1980s: A survey of 570 patients
2. Neuropsychiatric lupus
3. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
4. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus
5. Association between lupus psychosis and anti-ribosomal P protein antibodies
6. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus
7. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests
8. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus
9. Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens
10. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes
11. Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet activating factor concentrations and severity of bacterial meningitis
12. Cytokines in multiple sclerosis and its experimental models
13. Interleukin-1 and interleukin-6 are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activity markers
14. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement
15. Interferon-alpha in lupus psychosis
16. Central nervous system nitric oxide formation in cerebral systemic lupus erythematosus
17. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma
18. Reactive nitrogen intermediates in human neuropathology: An overview
19. The 1982 revised criteria for classification of systemic lupus erythematosus
20. Committee on Progress studies in SLE. Derivation of SLEDAI
21. A rapid and simple method for the measurement of nitrate in plasma by high performance capillary electrophoresis
22. Increased transforming growth factor-β, interleukin-4 and interferon-γ in multiple sclerosis
23. Oligoclonal IgG in cerebrospinal fluid detected by isoelectric focusing using PhastSystem
24. Tumor necrosis factor α in autoimmunity: Pretty girl or witch
25. Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients
26. Cytokine concentration in serum of lupus erythematosus patients: The effect on acute phase response
27. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus
28. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus
29. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematosus, progressive systemic sclerosis, and mixed connective tissue disease
30. Cytokine profile in interferon-β treated multiple sclerosis patients: Reduction of interleukin-10 mRNA expressing cells in peripheral blood
31. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlation with acute phase proteins
32. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus
33. Cerebrospinal fluid cytokine concentrations in a patient with lupus meningoencephalitis: Differences from cytokine profiles in central nervous system infections
34. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases
35. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma
36. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation
37. Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus
38. Correlation of serum measures of nitric oxide production with lupus disease activity
39. Magnetic resonance and cerebral proton spectroscopy in patients with systemic lupus erythematosus